U.S., Japan Biotech Deal: IDEC Pharmaceutical Corp....

U.S., Japan Biotech Deal: IDEC Pharmaceutical Corp. of La Jolla said it entered a partnership believed to be the first major marketing collaboration between private biotech firms from the United States and Japan. An IDEC statement said it had entered into an agreement with the Institute of Immunology Co. of Tokyo that will give the institute rights in Asia to certain IDEC products plus a chunk of IDEC stock in exchange for market penetration for IDEC that could be worth up to $23 million in sales over two years.